Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ebola virus protein 24 (VP24) is a multifunctional viral secondary matrix protein found in ebolaviruses. VP24 plays a critical role in virus assembly, nucleocapsid formation, and in suppressing the host innate immune response. It directly binds to karyopherin-α, thereby blocking the nuclear import of phosphorylated STAT1, an essential transcription factor in interferon signaling, and thus enables the virus to evade the host immune system[6][4]. VP24 is structurally distinct with a novel pyramidal or β–barrel fold, and is essential for the formation of functional, infectious viral particles and nucleocapsids[2][3][4][6]. It interacts with other viral and host proteins involved in nuclear membrane function and intracellular transport, further facilitating viral replication and egress[2][5][6]. VP24 is a promising target for antiviral research and structural studies have informed potential drug and neutralizing antibody design[4][6]. There are no approved drugs that specifically target VP24, but its central roles in infection and immune evasion make it of high therapeutic interest. If you are referring to a "VP24" from a non-Ebola or non-filovirus virus (for example, White spot syndrome virus in shrimp, also named VP24), let me know—the structure and function would be distinct[1].
Inhibition of STAT1-mediated interferon signaling by blocking karyopherin-α binding; Disruption of nuclear import of immune signaling proteins; Antagonism of host innate immunity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ebola virus protein 24 (VP24).